Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer1-Reference-Cited by-同舟云学术

Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer1

Published:2010-08-24 Issue:24 Volume:116 Page:5710-5715
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lara Primo N.,Chansky Kari,Shibata Taro,Fukuda Haruhiko,Tamura Tomohide,Crowley John,Redman Mary W.,Natale Ronald,Saijo Nagahiro,Gandara David R

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference14 articles.

1. Global cancer statistics;Parkin;CA Cancer J Clin.,2005

2. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database;Govindan;J Clin Oncol.,2006

3. Small cell lung cancer: treatment progress and prospects;Clark;Oncology (Huntington).,1998

4. Determinants of improved outcome in small cell lung cancer: an analysis of the 2,580 patient Southwest Oncology Group database;Albain;J Clin Oncol.,1990

5. Treatment of extensive small cell lung cancer;Davies;Hemat Oncol Clin N Am.,2004

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the ability of the Cancer and Aging Research Group tool to predict chemotherapy toxicity in older Japanese patients: A prospective observational study;Journal of Geriatric Oncology;2024-07

2. Comparison of Irinotecan/carboplatin versus Etoposide/carboplatin for extended disease small cell lung cancer (ED-SCLC): A systematic review and meta-analysis of randomized controlled trials;2024-03-07

3. Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer;European Journal of Clinical Pharmacology;2023-01-16

4. Cancer of the Lung;Holland‐Frei Cancer Medicine;2022-10-21

5. Phase 1b study of ramucirumab in combination with irinotecan plus cisplatin in chemo-naïve patients with extensive-stage small-cell lung cancer;Lung Cancer;2022-02